Skip to main content
Clinical Trials/NCT01571843
NCT01571843
Completed
Not Applicable

Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism

Columbia University1 site in 1 country12 target enrollmentFebruary 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Hyperparathyroidism
Sponsor
Columbia University
Enrollment
12
Locations
1
Primary Endpoint
Proportion of subjects with improved bone mass and bone quality at the 1/3 radius
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of the study is to determine the effect of forearm exercise on forearm bone density in post-menopausal women with or without primary hyperparathyroidism.

The investigators hypothesize that forearm exercise will increase forearm bone density in patients with primary hyperparathyroidism more so than in patients without primary hyperparathyroidism.

Detailed Description

Primary hyperparathyroidism (PHPT), a disease characterized by excess parathyroid hormone (PTH) and high blood calcium, is one of the most common endocrine disorders. PHPT is seen most often in post-menopausal women. Kidney stones and bone deformities were prominent manifestations of the disease in the past, however, PHPT is now primarily asymptomatic due to incidental detection of high blood calcium levels. Many patients with PHPT, however, have low bone mineral density (BMD) when bone mass is measured by dual energy x-ray absorptiometry (DXA), primarily at the forearm. There is no effective medical therapy which increases bone density at the forearm in patients with PHPT. PTH both builds and breaks down bone, and the pathways by which PTH mediates these actions are beginning to be identified. Prior research suggests that mechanical loading shifts PTH towards building bone. Arm exercise is an attractive option for the treatment of low forearm BMD in patients with PHPT since it is often the site most affected by excess PTH.

Registry
clinicaltrials.gov
Start Date
February 2010
End Date
October 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

John P. Bilezikian

Dorothy L. and Daniel H. Silberberg Professor of Medicine and Pharmacology

Columbia University

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for primary hyperparathyroidism group:
  • Primary hyperparathyroidism (defined by an elevated serum calcium and concomitantly elevated or inappropriately normal PTH)
  • Female sex, postmenopausal status for at least five years, ages 45-80
  • English- or Spanish-speaking
  • DXA T-score less than -1.0 at the one-third radius
  • Physically capable of exercise
  • 25-hydroxyvitamin D \>20 ng/mL. The latter inclusion criterion will lead to the enrollment of some individuals whose vitamin D stores will not be frankly low. We feel, however, that it is better to study subjects in their usual state rather than replacing them with vitamin D which could add another variable that would further complicate this pilot study.
  • Inclusion criteria for the osteopenic control:
  • Female sex, postmenopausal status for at least five years ages 45-80
  • English- or Spanish-speaking

Exclusion Criteria

  • Men, premenopausal women, women less than age 45 or greater than age 80
  • Familial hypocalciuric hypercalcemia
  • Current or prior use of bisphosphonates (alendronate or risedronate (within 12 months), ibandronate (within 6 months), other bisphosphonate (2 years)
  • Current use of cinacalcet
  • Current or prior use of estrogen replacement therapy (within 2 years)
  • Planned parathyroidectomy (within one year)
  • Planned initiation of bisphosphonates
  • DXA T-score greater than -1.0 at the one-third radius
  • Cardiovascular disease or uncontrolled hypertension
  • Exercise-limiting pulmonary diseases

Outcomes

Primary Outcomes

Proportion of subjects with improved bone mass and bone quality at the 1/3 radius

Time Frame: 1 year

The primary outcome is proportion of subjects with improved bone mass and bone quality at the 1/3 radius over one year.

Study Sites (1)

Loading locations...

Similar Trials